Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Shares Outstanding: 2012-2024

Historic Shares Outstanding for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to $157.7 million.

  • Ocular Therapeutix's Shares Outstanding rose 11.68% to $174.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.9 million, marking a year-over-year increase of 11.68%. This contributed to the annual value of $157.7 million for FY2024, which is 37.22% up from last year.
  • Per Ocular Therapeutix's latest filing, its Shares Outstanding stood at $157.7 million for FY2024, which was up 37.22% from $115.0 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Shares Outstanding ranged from a high of $157.7 million in FY2024 and a low of $76.0 million during FY2020.
  • Over the past 3 years, Ocular Therapeutix's median Shares Outstanding value was $115.0 million (recorded in 2023), while the average stood at $116.6 million.
  • Data for Ocular Therapeutix's Shares Outstanding shows a peak YoY spiked of 50.99% (in 2020) over the last 5 years.
  • Over the past 5 years, Ocular Therapeutix's Shares Outstanding (Yearly) stood at $76.0 million in 2020, then climbed by 0.97% to $76.7 million in 2021, then climbed by 0.61% to $77.2 million in 2022, then soared by 48.91% to $115.0 million in 2023, then skyrocketed by 37.22% to $157.7 million in 2024.